Compare EXEL & ORI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EXEL | ORI |
|---|---|---|
| Founded | 1994 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 11.4B |
| IPO Year | 2000 | N/A |
| Metric | EXEL | ORI |
|---|---|---|
| Price | $43.88 | $45.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 2 |
| Target Price | $45.18 | ★ $49.00 |
| AVG Volume (30 Days) | ★ 2.6M | 1.4M |
| Earning Date | 02-10-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.54% |
| EPS Growth | ★ 53.55 | N/A |
| EPS | 2.38 | ★ 3.32 |
| Revenue | $2,288,218,000.00 | ★ $8,748,900,000.00 |
| Revenue This Year | $9.79 | $10.22 |
| Revenue Next Year | $12.01 | $6.10 |
| P/E Ratio | $18.44 | ★ $13.76 |
| Revenue Growth | ★ 9.93 | 7.08 |
| 52 Week Low | $31.90 | $33.00 |
| 52 Week High | $49.62 | $46.76 |
| Indicator | EXEL | ORI |
|---|---|---|
| Relative Strength Index (RSI) | 52.40 | 55.96 |
| Support Level | $40.83 | $45.35 |
| Resistance Level | $47.24 | $46.76 |
| Average True Range (ATR) | 1.11 | 0.63 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 48.94 | 66.34 |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.